Trial Profile
Pharmacokinetics of Single and Multiple Oral Doses of 5 mg BI 1356 in Healthy Chinese Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2014
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 11 Jul 2014 New trial record